We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QSI:NASDAQQuantum-Si Incorporated Analysis

Data as of 2026-09-02 - not real-time

$0.76

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Quantum-Si incorporated trades at $0.7573, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. The last 30 days have lost 9.4%. RSI sits at 45.5, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $0.7100 and resistance at $0.9310.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 203.7% above the current price. Revenue is contracting at 41.8%.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 72.5%, a beta of 3.68 and a maximum drawdown of 73.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Quantum-Si Incorporated QSI came out with a quarterly loss of $0.BRANFORD, Conn., July 27, 2026 GLOBE NEWSWIRE -- Quantum-Si Incorporated Nasdaq: QSI “Quantum-Si,” “QSI” or the...Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.00
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.00
  • Analyst targets imply +203.7% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +203.7% versus the current price
  • Negative return on equity of -49.1%
  • Revenue contracting at -41.8%

Key Metrics & Analysis

Financial Health

Revenue Growth-41.80%
P/E Ratio-2.2
ROE-49.11%
ROA-25.71%
Debt/Equity1.80
P/B Ratio0.9
Op. Cash Flow$-92448000
Free Cash Flow$-50126000
Industry P/E30.6

Technical Analysis

TrendBearish
RSI45.5
Support$0.71
Resistance$0.93
MA 20$0.78
MA 50$0.82
MA 200$1.00
MACDBullish
VolumeIncreasing
Fear & Greed Index92.66

Valuation

Target Price$2.30
Upside/Downside203.71%
GradeUndervalued
TypeBlend

Risk Assessment

Beta3.68
Volatility72.50%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.